NCT01152515

Brief Summary

Tracheal extubation can be associated with hyperdynamic circulatory response. The investigators examined the effect of maintaining a remifentanil infusion on the cardiovascular response during extubation in propofol-remifentanil sedated patients after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2010

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 28, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 29, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
9.1 years until next milestone

Results Posted

Study results publicly available

March 18, 2020

Completed
Last Updated

March 27, 2020

Status Verified

March 1, 2020

Enrollment Period

9 months

First QC Date

June 28, 2010

Results QC Date

April 1, 2011

Last Update Submit

March 17, 2020

Conditions

Keywords

safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery

Outcome Measures

Primary Outcomes (3)

  • Mean Arterial Pressure Changes During Extubation

    10 min

  • HR Changes During Extubation

    10 min

  • The Grade of Coughing During Extubation

    Grade of cough was assessed on a four-point scale (0=no coughing, 1=single cough, 2=more than one episode of nonsustained coughing, 3=sustained and repetitive coughing with head lift).

    2 min

Secondary Outcomes (2)

  • Time of Awake

    1 hour

  • Time of Extubation

    1 hr

Study Arms (2)

Control

NO INTERVENTION

stopping of propofol and remifentanil infusion

Remifentanil

ACTIVE COMPARATOR

stopping of propofol and maintenance of remifentanil infusion

Drug: Remifentanil

Interventions

Control group : stopping of propofol and remifentanil infusion Remifentanil group : stopping of propofol and maintenance of remifentanil infusion

Remifentanil

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 20
  • Short term ventilator care after surgery in intensive care unit

You may not qualify if:

  • pneumonia
  • chronic obstructive lung disease
  • asthma
  • end stage renal disease
  • risk factors for aspiration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine

Seoul, 120-752, South Korea

Location

MeSH Terms

Interventions

Remifentanil

Intervention Hierarchy (Ancestors)

PropionatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Results Point of Contact

Title
Dr. Shin Ok Koh
Organization
Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

June 28, 2010

First Posted

June 29, 2010

Study Start

May 1, 2010

Primary Completion

February 1, 2011

Study Completion

February 1, 2011

Last Updated

March 27, 2020

Results First Posted

March 18, 2020

Record last verified: 2020-03

Locations